Verastem, Inc. (VSTM) Financials

VSTM Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 176.2 million 71.8 million
2023-06-30 191.8 million 69.0 million
2023-03-31 120.9 million 66.7 million
2022-12-31 95.1 million 47.7 million

VSTM Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -16.6 million 1.5 million
2023-06-30 -19.9 million 1.4 million
2023-03-31 -20.3 million 1.3 million
2022-12-31 -16.6 million 1.3 million

VSTM Net Income

No data available :(

VSTM Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 165.7 million - 1.7 million
2023-06-30 183.1 million 39.7 million 1.9 million
2023-03-31 111.2 million 39.6 million 2.1 million
2022-12-31 87.9 million 24.5 million 2.3 million

VSTM Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 26.8 million
2023-06-30 17.7 million
2023-03-31 16.7 million
2022-12-31 17.1 million

VSTM Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 13.9 million 7.4 million -
2023-06-30 - 12.9 million 7.4 million -
2023-03-31 - 12.0 million 7.3 million -
2022-12-31 - 10.7 million 6.1 million -

VSTM Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 5000
2023-06-30 - 22000
2023-03-31 - 30000
2022-12-31 2.6 million 29000

VSTM

Price: $10.90

52 week price:
4.32
15.12

Earnings Per Share: -3.96 USD

P/E Ratio: -3.43

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 245000

Ebitda: -22.9 million

Market Capitalization: 297.0 million

Links: